Researchers use XAI to unlock secrets of drug discovery

Artificial intelligence (AI) has exploded in popularity. It powers models that help us drive vehicles, proofread emails and even design new molecules for medications.

Merck, AstraZeneca receive approval for Lynparza in Japan

August 25, 2023

Numinus Wellness Provides Corporate Update | Psychedelic Invest

VANCOUVER, BC, April 15, 2024 /CNW/ – Numinus Wellness Inc. (“Numinus” or the “Company“) (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing traditional and innovative behavioral health

April 15, 2024

Oncology Drug Shortages Persist, but Continue to Evolve

The nation’s cancer centers continue to grapple with shortages of commonly used oncology drugs, according to a new survey. Overall, 89% of centers that responded

June 27, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.